Your institution may have access to this item. Find your institution then sign in to continue.
Title
Tetrabenazine.
Authors
Hayden, Michael R.; Leavitt, Blair R.; Yasothan, Uma; Kirkpatrick, Peter
Abstract
In August 2008, tetrabenazine (Xenazine; Ovation Pharmaceuticals/Biovail) was approved by the US FDA for the treatment of chorea associated with Huntington's disease. This makes it the first treatment to be approved in the US for a symptom of this neurodegenerative disorder.
Publication
Nature Reviews Drug Discovery, 2009, Vol 8, Issue 1, p17